Alan Edrick
Analyst · CJS Securities. Your line is open
Thank you, Deepak. Now I will review the financial results for our 2020 first fiscal quarter in greater detail. As mentioned previously, our revenues in Q1 of fiscal 2020 were up 9% year-over-year. Revenues in the security division reached a record Q1 level of $189 million, an increase of 11% from Q1 of fiscal 2019, driven primarily by growth in the cargo and RTT product lines. The Opto division continued its impressive performance, with revenues increasing 4% year-over-year to a new Q1 record of $74 million. This increase was driven by 6% in external revenues, partially offset by a reduction in intercompany revenues. Our health care division posted solid revenue growth of 5% driven by U.S. demand, which was leveraged to significant growth and profits. The Q1 gross margin of 34.1% was down from 36% in the same quarter last year. Though we saw gross margin expansion in our Opto and health care divisions, reduced gross margin in the security division, due to the mix of revenues resulted in the overall reduction. With respect to the security mix, security product revenues were up 24% while security service revenues were down 5%. Security product sales tend to have lower gross margin than security service sales, thus resulting in a reduced overall gross margin. As mentioned on previous calls, our gross margin will fluctuate from period to period, based on a revenue mix among other factors. Moving operating expenses, SG&A expenses were up slightly by 0.8% year-over-year. However, as a percentage of sales, SG&A expenses decreased to 21.4% in Q1 of fiscal 2020 from 23.2% in Q1 of the prior year, which evidences our diligent efforts across all of our divisions to improve efficiencies, and prudently manage our cost structure. R&D expenses in Q1 were $14.2 million up 4% from Q1 of the prior year, largely due to activity in the security division. We remain focused on innovative product development, which we view as vital to the long term success of our business. In Q1 of fiscal 2020, we recorded a $2.1 million benefit in restructuring and other charges, due primarily to insurance recoveries of legal costs, compared to a $4.2 million charge we took in Q1 at fiscal 2019. Moving to Interest and then taxes. Interest and other expense in Q1 of fiscal 2020 decreased to $4.7 million from $5.3 million in the same prior period a year ago, as a result of lower average borrowings, due to the strong trailing year cash flow, and lower average interest rates under our credit facility. On the tax side, excluding the impact of discrete tax items, our effective tax rate in Q1 of fiscal 2020 was 27.9% compared to 28.1% in the first quarter of fiscal 2019. We recognized discrete tax benefit of 6.2 million for equity based compensation in Q1 of this fiscal year, compared to a 1.5 million tax benefit for equity based compensation in the same prior year period. As a result, we reported a tax benefit and resulting negative tax rate of 2.9% in Q1 of fiscal 2020 compared to a positive tax rate of 13.9% in Q1 of fiscal 2019. I will now turn to a discussion of our non-GAAP adjusted operating margin, which excludes restructuring and other charges, and amortization expense of enquired intangible assets. The company's non-GAAP adjusted operating margin in Q1 of fiscal 2020 was 9.1% comparable to the 9.2% in Q1 of fiscal 2019. Similar to gross margin as I mentioned earlier, we saw year-over-year operating margin increases in our Opto and Healthcare divisions, offset by a reduction in operating margins in the security division. The Opto division's operating margin expanded significantly from 11.7% in Q1 last year to a Q1 record 13.0% in fiscal 2020. The Healthcare division reported a nice turnaround from negative 4.4% in Q1 last fiscal year to 7% in Q1 of fiscal 2020. With incremental investment in R&D and the change in gross margin previously noted, the security divisions operating margin was 12.2%. Moving to cash flow. In Q1 of fiscal 2020, we generated $24.8 million in operating cash flow compared to negative $2.8 million in Q1 of the last fiscal year. This strong Q1 fiscal 2020 cash flow was driven by increased profits, improved inventory management as days inventory on hand decreased to 128 days in Q1 of fiscal 2020 from 184 days in Q1 of fiscal 2019 and increased customer advances. This was partially offset by an increase in days sales outstanding to 77 days in Q1 of fiscal 2020 from 76 days in Q1 of fiscal 2019. CapEx in the quarter was 6 million, which included investment for turnkey projects, while depreciation and amortization expense was 13.5 million. We were active in our stock buyback program in the 2020 first fiscal quarter acquiring approximately 126,000 shares. As of September 30th, 2019 436,000 shares approximately were available for additional repurchase under the program. Our balance sheet remains strong. We ended the quarter with net leverage of approximately 1.4. Finally, turning to guidance. For fiscal year 2020, we are increasing our guidance for revenues to a range of $1.238 billion to $1.273 billion, and our guidance for non-GAAP earnings per diluted share has increased to a range of $4.61 to $4.83. This non-GAAP diluted EPS range does not reflect potential impairment, restructuring and other charges, amortization of acquired intangible assets, and non-cash interest expense and their associated tax effects, as well as discrete tax items. We currently believe the sales and non-GAAP earnings guidance reflect reasonable estimates. Actual sales and non-GAAP earnings, however, could vary from the anticipated ranges, due to the risks and uncertainties specifically affecting our business, and generally affecting industries in which we operate. These risks and uncertainties include items beyond our control, such as site readiness for product installations, evolving government trade policies, customer acceptance of our products and the timing of orders and contract renewals in each division, and other risks and uncertainties discussed in our SEC filings. We have continued to focus on the growth of our business while investing in product development, making selective strategic acquisitions and managing our cost structure. We believe these efforts will enable OSI to continue our leadership role, with innovative products and solutions across our various industries. Thank you for participating on this conference call and at this time, we would like to open the call to questions.